Exclusive Agents
Intensive Care Unit Equipment Manufacturer
.MEK-ICS Co., Ltd. is making continuous efforts to improve the quality of our clients’ lives and fulfill the idea of respecting human life through technology
Since its establishment, MEK-ICS has persistently created social value throughout lifesaving technology and service that improves the quality of life. The company name MEK-ICS, stands for Medical Equipment of Korea Intensive Care System. It is the only company in Korea that focuses on medical appliances for critical patients. By specializing and advancing relevant technology, it is establishing its identity and aims to grow its market worldwide
Despite its short history, we are confident that our hard work and accomplishment will have a significant impact in the medical appliance market for critical patients. Starting with leading the technology for patient monitors in Korea, MEK-ICS Co., Ltd. has developed an artificial respiration device and positive airway pressure devices for at-home use for the first time in Korea. Also, MEK-ICS Co., Ltd. has grown to be the only company in the Pan-Asia area that has the ability to produce artificial respirators and nebulizers throughout a world-class production of combined nebulizers and development of software-type high frequency artificial respiration technology.
MEK-ICS Co., Ltd. is a young company that still has a long way to go. It will not be satisfied with the existing descriptions such as “the first in Korea”, “pioneer in the medical appliance market for critical patients”, and “the only company in Asia”. It will continue its continuous technology development and challenge the worldwide market. We promise to make our utmost efforts to fulfill the company’s growth and the happiness of clients, stockholders and officials.
XENIOS AG
XENIOS is dedicated to translating medical need into pioneering therapies and devices together with caregivers and patients.
Novalung was formed back in 2003. In 2011, the Aachen-based Medos AG was acquired by Novalung with the aim of extending Medos’ blood pump expertise and blood pump technology for use with lung therapies. Compared to other pumps, the pulsatile blood pump system offered by Medos was ideal for this kind of use. This also enabled the company to expand its overall product spectrum to offer both lung and heart support. This makes sense anatomically, since coronary and pulmonary circulation are interrelated. Logically, therefore, products are based on a single technology and use the same platform. The first joint project that resulted is i-cor: syncronized cardiac assist for treatment of cardiogenic shock and circulatory support during cath lab interventions.
Despite its short history, we are confident that our hard work and accomplishment will have a significant impact in the medical appliance market for critical patients. Starting with leading the technology for patient monitors in Korea, MEK-ICS Co., Ltd. has developed an artificial respiration device and positive airway pressure devices for at-home use for the first time in Korea. Also, MEK-ICS Co., Ltd. has grown to be the only company in the Pan-Asia area that has the ability to produce artificial respirators and nebulizers throughout a world-class production of combined nebulizers and development of software-type high frequency artificial respiration technology.
In 2013, an initial step was then taken towards a full merger of these two businesses with the formation of a parent holding company, XENIOS.
Surgiris
Surgiris is headquartered in Croix, on the outskirts of Lille in northern France, at the crossroads between Paris, London and Brussels. For the last 15 years, the company has designed manufactured and marketed surgical lights, distribution columns and ceiling pendants for operating theatres.
Three core values underpin Surgiris’s business strategy and day-to-day practices: innovation, quality and customer service.
Dima Italia S.r.l.
DIMA ITALIA is an Italian company leader in designing, manufacturing and marketing respiratory devices dedicated to the acute and homecare market.
Almost 4 decades of experience and the continuous exchange of information with health professionals and ventilator users allowed us to reach highest quality and easy-to-use therapeutic products. We are passionate about what we do, and strive to improve patient outcome for a higher quality of life.
Our mission is to constantly improve our devices in terms of liability, time endurance, with a special attention to therapeutic effectiveness.
DIMA ITALIA products are sold worldwide through a growing distribution network, supported by the DIMA ITALIA’s sales and service departments.
PERIMED AB
Perimed AB, established in 1981 and headquartered just outside Stockholm, is the world leader in developing, manufacturing and marketing state-of-the-art equipment for microvascular diagnosis. With customers in more than 80 countries, Perimed also actively participates in a wide range of research projects together with leading universities to deepen our understanding of diseases related to blood perfusion and microvascular functions. Knowledge gained is continually re-invested in further development.
Perimed has subsidiaries in the UK, United States, France, Italy, Germany, Mainland China and Hong Kong. Customers and sales leads in other countries are either supported by local representatives or directly from the company’s headquarters. Perimed’s policy and ambition are that all researchers and clinicians shall be offered expert help to select the optimum equipment for their application, followed by thorough after-sales training in Sweden. Training includes teaching in microcirculation, physiology and use of the equipment to achieve optimum results in the shortest time. After so many years of experience in the microcirculation field, we have a broad knowledge in most applications in animal research as well as in clinical work.
Links Products :
